Summary paper on the 2023 European Association of Urology guidelines on the management of non-neurogenic male lower urinary tract symptoms

S Gravas, M Gacci, C Gratzke, TRW Herrmann… - European urology, 2023 - Elsevier
Context Lower urinary tract symptoms (LUTS) are common, often bothersome, and have
multifactorial aetiology. Objective To present a summary of the 2023 version of the European …

Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline part I—initial work-up and medical management

LB Lerner, KT McVary, MJ Barry, BR Bixler… - The Journal of …, 2021 - auajournals.org
Purpose: Benign prostatic hyperplasia (BPH) is a histologic diagnosis describing
proliferation of smooth muscle and epithelial cells within the prostatic transition zone. The …

Future platforms of robotic surgery

SL Alip, J Kim, KH Rha, WK Han - Urologic Clinics, 2022 - urologic.theclinics.com
The birth of robots in surgery and the idea of telepresence arose from necessity. One of the
factors that drove these innovations was the need to provide surgical services to soldiers in …

[PDF][PDF] Five-year outcomes for Aquablation therapy compared to TURP: results from a double-blind, randomized trial in men with LUTS due to BPH

PJ Gilling, N Barber, M Bidair, P Anderson, M Sutton… - Can J Urol, 2022 - canjurol.com
Materials and methods: In a double-blinded, multicenter prospective randomized controlled
trial, 181 patients with moderate to severe LUTS secondary to BPH underwent TURP or …

Impact of surgery for benign prostatic hyperplasia on sexual function: a systematic review and meta-analysis of erectile function and ejaculatory function

C Manfredi, B Garcia-Gomez, D Arcaniolo… - European urology …, 2022 - Elsevier
Context Several sexual side effects, including erectile, ejaculatory, and orgasmic
dysfunction, were reported with the majority of surgical procedures for benign prostatic …

The role of novel minimally invasive treatments for lower urinary tract symptoms associated with benign prostatic hyperplasia

S Madersbacher, CG Roehrborn, M Oelke - BJU international, 2020 - Wiley Online Library
Objectives To provide an update on novel minimally invasive lower urinary tract symptoms
associated with benign prostatic hyperplasia (LUTS/BPH) treatments in a non‐systematic …

Aquablation therapy in large prostates (80–150 cc) for lower urinary tract symptoms due to benign prostatic hyperplasia: WATER II 3‐year trial results

KC Zorn, M Bidair, A Trainer, A Arther… - BJUI …, 2022 - Wiley Online Library
Objective The objective of this study is to determine if Aquablation therapy can maintain its
effectiveness in treating men with lower urinary tract symptoms (LUTS) due to benign …

New technologies for treatment of benign prostatic hyperplasia

D Elterman, B Gao, S Lu, N Bhojani, KC Zorn… - Urologic …, 2022 - urologic.theclinics.com
Benign prostatic hyperplasia (BPH) is a ubiquitous disease that affects 50% of men at age
60 years and 90% of men aged older than 80 years. 1, 2 Bothersome lower urinary tract …

Minimally invasive therapies for benign prostatic obstruction: a review of currently available techniques including prostatic artery embolization, water vapor thermal …

T Bilhim, P Betschart, P Lyatoshinsky… - CardioVascular and …, 2022 - Springer
A 66-years old male patient presents with lower urinary tract symptoms, mostly due to
obstructive symptoms, and an enlarged prostate with 80 cm3, with a broad-based median …

Water vapor thermal therapy of lower urinary tract symptoms due to benign prostatic obstruction: efficacy and safety analysis of a real-world cohort of 211 patients

K Bausch, L Zahiti, M Schrutt, C Wetterauer… - World Journal of …, 2023 - Springer
Purpose This study assessed the efficacy, safety and durability outcomes of water vapor
thermal therapy with Rezum in a real-world cohort of patients with lower urinary tract …